AiRuiKa 艾瑞卡 200mg Camrelizumab For Injection Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic Name	Camrelizumab for Injection
Trade Name	艾瑞卡 AiRuiKa
Specification	200mg/vial
Main ingredients	Camrelizumab
Appearance	This product is white to white powder or lump.
Manufacturer	Suzhou Shengdiya Biomedical Co., Ltd   苏州盛迪亚生物医药有限公司

 

 

Indications:
1. This product is indicated for the treatment of patients with relapsed or refractory classic Hodgkin's lymphoma who have undergone at least second-line chemotherapy.
2. This product is indicated for the treatment of patients with advanced hepatocellular carcinoma who have previously received Sorafenib therapy and/or oxaliplatin system chemotherapy.
3. This product in combination with pemetrexed and carboplatin, is indicated for the first-line treatment of epidermal growth factor receptor (EGFR) gene mutation-negative and Alk-negative, inoperable locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC).
4. This product is used for the treatment of patients with locally advanced or metastatic esophageal squamous cell carcinoma with disease progression or intolerance after previous first-line chemotherapy.
5. It is used for the treatment of advanced nasopharyngeal carcinoma patients with disease progression or intolerance after receiving second-line or above chemotherapy.
6. This product is used in combination with cisplatin and gemcitabine for the first-line treatment of patients with locally relapsed or metastatic nasopharyngeal carcinoma. 
7. This product combined with taxone and cisplatin is used for the first-line treatment of patients with unresectable locally advanced/relapsed or metastatic esophageal squamous cell carcinoma. 
8. This product is used in combination with paclitaxel and carboplatin for the first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer.

 

 

 

 

 

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

 

Hot Tags: AiRuiKa 艾瑞卡 200mg Camrelizumab For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, Acarbose Tablets, Reference Listed Drugs, Alfacalcidol Soft Capsules, Bimatoprost Ophthalmic, Olanzapine Tablets

• Previous: Fabrazyme 5mg 35mg Agalsidase Beta For Injection Reference Listed Drug
• Next: VALDOXAN 25mg Agomelatine Tablets Reference Listed Drug